John Bentivoglio, CEO and President of Event Cardio Group, is Featured in an Exclusive New Interview at

AUSTIN, Texas, Aug. 16, 2016 (GLOBE NEWSWIRE) --, Inc. (SCV) and Event Cardio Group, Inc. (OTCQB:ECGI) announced today that a new audio interview with the Company, is now available. The interview can be heard at

John Bentivoglio, CEO and President of Event Cardio Group called in to to go over his Company's exciting business model, recent news and goals for 2016. Recently ECGI raised $300,000 in a private placement and also announced the recent acquisition of National Cardiac Monitoring Center and Health Canada's clearance of ECGI’s NowCardio™ heart monitoring system.

Bentivoglio stated, “I enjoyed talking about our medical diagnostic equipment that focuses on the detection, and preventive treatment of high-risk diseases, our target markets, and our plans for 2016.’s audio presentations are disseminated through the web and to our shareholder base making it a powerful way to get our story to a wider audience.”

About is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit

About Event Cardio Group, Inc.

Event Cardio Group, Inc. is a developer of medical diagnostic equipment that focuses on the detection, and preventive treatment, of high-risk diseases. The Company's core product is NowCardio™, an Advanced Ambulatory Arrhythmia Monitoring System, which offers the combined functionality of holter monitoring, event recording, and mobile cardiac telemetry simultaneously within in a single device. For more information on the company please visit

Statements in this release may be regarded, in certain instances, as "forward-looking statements" pursuant to certain sections of the Securities Act 1933 and the Securities Exchange Act 1934, respectively. "Forward-looking statements" are based on expectations, estimates and projections at the time the statements are made, and involve risks and uncertainties, which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting Event Cardio Group, Inc. and its business. There can be no assurance that such forward-looking statements will ever prove to be accurate and readers should not place undue reliance on any such forward-looking statements contained herein. Event Cardio Group, Inc. will not republish revised forward-looking statements to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

For Stuart T. Smith 512-267-2430;Event Cardio Group, Inc.